NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spirair, Inc.

Spirair, Inc.

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://spirair.com/

Last Round

Series B

Mar 10, 2026

Total Funding Raised

$22.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Spirair, Inc. is a medical device company that develops minimally invasive solutions for otolaryngologists to improve patient care for nasal obstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioabsorbable implantsotolaryngologyENTnasal airway obstructionseptoplastynasal septal deviationminimally invasive surgerymedical devicesinus surgerybioabsorbablenasal implantsresorbable implantscartilage-sparingambulatory surgery center

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spirair, Inc. Comparables

Compare Spirair, Inc. with similar companies based on industry and business-model similarity.

Spirair, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aerin Medical
80%
Stryker Corporation
79%
Medtronic
77%

Spirair, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 10, 2026
Series BAug 12, 2025
Series AAug 1, 2021

Key People

Founding team and executive leadership

Benjamin Bishop

Chief Executive Officer

Executive Team

Spirair, Inc. Investors

Notable investors and investment history

Spirair, Inc. investors
InvestorRounds
Cadence Healthcare VenturesSeries B
View VenturesSeries A, Series B
1809 CapitalSeries B
Sonder CapitalSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    $25M round completed.

Spirair, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spirair, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spirair, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range27
Year Founded2020
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.